Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53
Titel:
Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53
Auteur:
Chiorean, E. Gabriela Sanghani, Sonal Schiel, Marissa A. Yu, Menggang Burns, Matthew Tong, Yan Hinkle, David T. Coleman, Nicki Robb, Bruce LeBlanc, Julia Clark, Romnee Bufill, Jose Curie, Colleen Loehrer, Patrick J. Cardenes, Higinia